Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Pharmyn ApS
APS
Active
Advertising protection
CVR 37133892
Jernbanegade 27, 6000
Kolding
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2015 · 10 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Pharmyn ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Gross profit
12
-20
10
7
-12
Staff expenses
-0
-0
-0
-0
-0
EBITDA
12
-20
10
7
-12
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
12
-20
10
7
-12
Net financials
-0
-0
-0
0
0
Profit before tax
12
-20
10
7
-12
Tax
-0
-0
-0
-0
-0
Net profit
12
-20
10
7
-12
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
44
31
29
37
25
Equity
34
14
24
31
19
Long-term debt
0
0
0
0
0
Short-term debt
10
17
5
6
6
Total debt
10
17
5
6
6
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1245700.0%
This company
2021
2025
Equity ratio
75.1%
This company
38.2%
Market median
+97% vs market
2021
2025
Return on equity
-66.5%
This company
18.4%
Market median
-461% vs market
2021
2025
Net profit margin (of gross profit)
-1240900.0%
This company
2021
2025
Asset turnover (of gross profit)
-0.50×
This company
2021
2025
Debt / equity
0.33×
This company
0.62×
Market median
+47% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Pharmyn ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
